Efficacy of re-resection versus radiofrequency ablation for recurrent Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma (HCC) after resection for primary HCC

Xieling Yin, Tianqi Hua, Chi Liang, Zhong Chen

Translational Cancer Research · 2019 · 21 citations · 26 references

DOIFull text

Open access

Abstract

RSR and RFA have similar survival benefits in the treatment of recurrent BCLC stage 0/A HCC. RFA is superior to RSR in terms of hospital stay and incidence of treatment-related complications.

References

26